Fimasartan
Showing 1 - 25 of 76
Essential Hypertension Trial in Bucheon-si (Fimasartan + Indapamide, Fimasartan + Indapamide )
Recruiting
- Essential Hypertension
- Fimasartan + Indapamide
- Fimasartan + Indapamide placebo
-
Bucheon-si, Kyunggi-do, Korea, Republic ofThe Catholic University of Korea, Bucheon St.Mary's Hospital
May 18, 2023
A Combination Drug Including Fimasartan and Statins in
Completed
- Hypertension and Dyslipidemia
- Combination drug containing fimasartan and statins
-
Gwangju, Jebong-ro, Jangseong-eup, Jangseong-gun, Korea, Republic ofChonnam National University Hospital
Nov 15, 2022
Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
Recruiting
- Hypertension,Essential
-
Seoul, Korea, Republic ofSeoul National University Bundang Hospital
Jul 7, 2022
Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)
Not yet recruiting
- Essential Hypertension
- Primary Hypercholesterolemia
- Fimasartan
- +3 more
-
Seoul, Korea, Republic ofSeverance Hospital
Jun 26, 2023
Hypertension, Atherosclerosis, Diabetes, Type 2 Trial in Seongnam (Fimasartan)
Recruiting
- Hypertension
- +3 more
- Fimasartan
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Dec 27, 2021
Essential Hypertension Trial in Seoul (Fimasartan/Amlodipine)
Completed
- Essential Hypertension
-
Seoul, Korea, Republic ofBoryung Pharmaceutical Co., Ltd
Jul 28, 2021
Renoprotective Effect of Fimasartan in DKD and Proteinuria
Recruiting
- Diabetic Kidney Disease
- +2 more
-
Seoul, Korea, Republic ofSeverance hospital, Yonsei University Health System
Oct 7, 2021
Hypertension Trial in Gyeonggi-do (BR1015-1, BR1015-2, BR1015-1 + BR1015-2)
Completed
- Hypertension
- BR1015-1
- +2 more
-
Gyeonggi-do, Seongnam-si, Korea, Republic ofCHA Bundang Medical Center, CHA University
Nov 18, 2021
FimasaRtan-basEd BP Targets After Drug SwitcHing
Completed
- Essential Hypertension
-
Suwon, Korea, Republic ofAjou University Hospital
Dec 22, 2020
The Elderly (= 70 Years) With Essential Hypertension Trial in Seoul (Fimasartan or Fimasartan/Hydrochlorothiazide, Perindopril
Completed
- The Elderly (≥ 70 Years) With Essential Hypertension
- Fimasartan or Fimasartan/Hydrochlorothiazide
- Perindopril or Perindopril/Indapamide
-
Seoul, Korea, Republic ofSeoul National University Bundang
Mar 19, 2020
Hypertension, Diabetes Trial in Seoul (Treatment A (Fimasartan, Linagliptin), Treatment B (Fimasartan/Linagliptin))
Completed
- Hypertension
- Diabetes
- Treatment A (Fimasartan, Linagliptin)
- Treatment B (Fimasartan/Linagliptin)
-
Seoul, Dahak-ro, Korea, Republic ofSeoul National University Hospital
Feb 3, 2020
Essential Hypertension, Dyslipidemia Trial in Seoul (Fimasartan 120mg, Atorvastatin 40mg, Placebo for Fimasartan 120mg)
Completed
- Essential Hypertension, Dyslipidemia
- Fimasartan 120mg
- +3 more
-
Seoul, Korea, Republic ofSeverance Hospital
Nov 4, 2019
Essential Hypertension, Dyslipidemia Trial in Seoul (Fimasartan/Amlodipine, Rosuvastatin, Fimasartan/Amlodipine, Fimasartan,
Completed
- Essential Hypertension
- Dyslipidemia
- Fimasartan/Amlodipine, Rosuvastatin
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 7, 2019
Fimasartan Blood Pressure Lowering After Acute Stroke
Completed
- Hypertension
- +2 more
-
Ansan, Korea, Republic of
- +26 more
Nov 1, 2019
Arterial Hypertension Trial in Russian Federation (Fimasartan, Losartan)
Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction Trial in Ostrava (Nebivolol, Valsartan and Sacubitril,
Not yet recruiting
- Cardiovascular Diseases
- Heart Failure With Reduced Ejection Fraction
- Nebivolol
- +5 more
-
Ostrava, Czech Republic, CzechiaUniversity Hospital Ostrava
Sep 6, 2023
Pharmacokinetics Trial in Seoul (Treatment T, Treatment R)
Completed
- Pharmacokinetics
- Treatment T
- Treatment R
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Jan 8, 2019
Drug-Drug Interaction Trial in Busan (Fimasartan/Amlodipine combination drug, Hydrochlorothiazide)
Completed
- Drug-Drug Interaction
- Fimasartan/Amlodipine combination drug, Hydrochlorothiazide
-
Busan, Korea, Republic ofInje University Busan Paik Hospital
Aug 8, 2018
Coronary Artery Disease Trial in Gwangju, Seoul, Ulsan (Fimasartan, Placebo)
Terminated
- Coronary Artery Disease
- Fimasartan
- Placebo
-
Gwangju, Korea, Republic of
- +2 more
Jun 19, 2018
Essential Hypertension Trial (Fimasartan 60 mg group, Fimasartan 120 mg group, Reference (Valsartan 80 mg) group)
Completed
- Essential Hypertension
- Fimasartan 60 mg group
- +2 more
- (no location specified)
Feb 19, 2018
Hypertension Trial (Fimasartan/Amlodipine, Fimasartan + Amlodipine)
Completed
- Hypertension
- Fimasartan/Amlodipine
- Fimasartan + Amlodipine
- (no location specified)
Jan 7, 2018
Hypertension Trial (Fimasartan, Losartan (Control))
Completed
- Hypertension
- Fimasartan
- Losartan (Control)
- (no location specified)
Mar 15, 2018